Infant ALL is characterized by a high frequency of KMT2A (also known as MLL) gene rearrangement (KMT2A-r) which is found in ~75% of cases and is associated with CD10-negative immature B-cell precursor phenotype and an extremely poor prognosis3–5. This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.